Regulation of sarco(endo)plasmic reticulum Ca2+ adenosine triphosphatase by phospholamban and sarcolipin: implication for cardiac hypertrophy and failure.

Michio Asahi, Hiroyuki Nakayama, Michihiko Tada, Kinya Otsu

Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Suita, Japan.

Trends in cardiovascular medicine 2003 May

filter terms:

The cardiac isoform of sarco(endo)plasmic reticulum Ca(2)(+) adenosine triphosphatase (SERCA2a) plays an important role in the contraction and relaxation of cardiac muscle. Phospholamban (PLN) and its homologue sarcolipin (SLN) are the endogenous regulators of SERCA2a. Evidence is accumulating that SERCA2a is intimately involved in the pathogenesis of cardiac hypertrophy and failure. Recent studies using genetically engineered animals revealed the implication of PLN for the development of cardiomyopathic phenotypes. This review focuses on advances in the understanding of molecular regulation of SERCA2a by PLN and SLN, and their implications for cardiac hypertrophy and failure in vivo.

Citation

Michio Asahi, Hiroyuki Nakayama, Michihiko Tada, Kinya Otsu. Regulation of sarco(endo)plasmic reticulum Ca2+ adenosine triphosphatase by phospholamban and sarcolipin: implication for cardiac hypertrophy and failure. Trends in cardiovascular medicine. 2003 May;13(4):152-7